The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 25, 2014

Filed:

Dec. 23, 2010
Applicants:

Laurent Vecellio-none, Chambray les Tours, FR;

Gilles Chantrel, Saint Etienne, FR;

Michel Massardier, Saint Etienne, FR;

Inventors:

Laurent Vecellio-None, Chambray les Tours, FR;

Gilles Chantrel, Saint Etienne, FR;

Michel Massardier, Saint Etienne, FR;

Assignees:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 37/00 (2006.01); A61M 15/08 (2006.01); A61M 11/02 (2006.01); A61M 15/00 (2006.01); A61M 11/00 (2006.01); A61M 11/08 (2006.01); A61M 16/00 (2006.01);
U.S. Cl.
CPC ...
A61M 15/08 (2013.01); A61M 11/02 (2013.01); A61M 15/0091 (2013.01); A61M 11/001 (2014.02); A61M 15/0098 (2014.02); A61M 11/08 (2013.01); A61M 2016/0027 (2013.01); A61M 2205/073 (2013.01); A61M 2210/0618 (2013.01); A61M 2210/0625 (2013.01); A61M 2210/0681 (2013.01);
Abstract

A device for administration of an aerosol includes a generator of particles of size between 10 nm and 200 um, a mouthpiece or mouth mask for oral administration of the aerosol during the nasal exhalation phase or during the respiratory pause phase preceding nasal exhalation, and a source of gas or pressure for conveying the particles. The mouthpiece is airtight, extends beyond the teeth of the patient by a maximum length of 4 cm, and administers the aerosol for the nasal cavities, the rhinopharynx or the paranasal sinuses during aerosol administration phases, such that the is successively applied to the mouth, the rhinopharynx and then the nasal fossae and the sinuses, and then the aerosol escapes via one or both of the patient's nostrils. The device does not allow exhalation via the mouth during aerosol administration phases, and the aerosol particles not being directed to the lungs.


Find Patent Forward Citations

Loading…